Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203019 · ClinicalTrials.gov registry record · Phase 4
Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT02203019 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 36 participants.
The verdict
NCT02203019, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
Patients with infections in their blood often become very sick. These patients are usually put in an intensive care unit for careful observation and treatment. These patients may develop a low blood pressure, lung failure, and kidney failure. When these problems develop, care becomes quite complicated. Patients with lung failure often need help with a breathing machine to make certain that the breathing is adequate. The machine helps keep the oxygen level high enough for healthy tissues. When patients are placed on the machine for breathing they require a tube to be placed into lungs. This can be quite uncomfortable. These patients need sedation to help them tolerate the uncomfortable breathing tube and other parts of their routine necessary care. This study will compare two drugs (dexmedetomidine and propofol) which are frequently used for sedation in intensive care patients. Clinical studies suggest that these drugs are both effective and safe. The main question is whether or not one of the drugs is better in a patient with a blood infection. This study will try to determine that. Our main goal is to see whether or not patients on one particular drug come off the breathing machine faster than patients on the other drug. These drugs are not experimental drugs and are approved by the Food and Drug Administration. There is no placebo drug being used in this study. All patients in this study will receive the best possible care based on their medical condition.
Interventions
- DRUG Dexmedetomidine
- DRUG Propofol
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-09-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02203019
The ClinicalTrials.gov registry entry for NCT02203019 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexmedetomidine is the first listed.
NCT02203019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02203019 about?
NCT02203019 is a clinical study titled "Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure". Patients with infections in their blood often become very sick. These patients are usually put in an intensive care unit for careful observation and treatment. These patients may develop a low blood pressure, lung failure, and kidney failure. When these problems develop, care becomes quite complicat...
What is the current status of trial NCT02203019?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2014-08. Estimated completion is 2016-09-22.
What interventions are being tested in trial NCT02203019?
The interventions under investigation include: Dexmedetomidine (DRUG), Propofol (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT02203019?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.